Author response for 'Metformin use is associated with a decrease in risk of hospitalization and mortality in COVID ‐19 diabetic patients: a population‐based study in Lombardy'

MLA

null Luisa Ojeda‐Fernández, et al. Author Response for “Metformin Use Is Associated with a Decrease in Risk of Hospitalization and Mortality in COVID ‐19 Diabetic Patients: A Population‐based Study in Lombardy.” Jan. 2022. EBSCOhost, https://doi.org/10.1111/dom.14648/v2/response1.

APA

null Luisa Ojeda‐Fernández, null Andreana Foresta, null Giulia Macaluso, null Pierluca Colacioppo, null Mauro Tettamanti, null Antonella Zambon, null Stefano Genovese, null Ida Fortino, null Olivia Leoni, null Maria Carla Roncaglioni, & null Marta Baviera. (2022). Author response for “Metformin use is associated with a decrease in risk of hospitalization and mortality in COVID ‐19 diabetic patients: a population‐based study in Lombardy.” https://doi.org/10.1111/dom.14648/v2/response1

Chicago

null Luisa Ojeda‐Fernández, null Andreana Foresta, null Giulia Macaluso, null Pierluca Colacioppo, null Mauro Tettamanti, null Antonella Zambon, null Stefano Genovese, et al. 2022. “Author Response for ‘Metformin Use Is Associated with a Decrease in Risk of Hospitalization and Mortality in COVID ‐19 Diabetic Patients: A Population‐based Study in Lombardy,’” January. doi:10.1111/dom.14648/v2/response1.